Skip to main content
SpringerLink
Log in

Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease

  • Review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract

Excitatory amino acid transporters (EAATs) are high-affinity Na+-dependent carriers of major importance in maintaining glutamate homeostasis in the central nervous system. EAAT3, the human counterpart of the rodent excitatory amino acid carrier 1 (EAAC1), is encoded by the SLC1A1 gene. EAAT3/EAAC1 is ubiquitously expressed in the brain, mostly in neurons but also in other cell types, such as oligodendrocyte precursors. While most of the glutamate released in the synapses is taken up by the “glial-type” EAATs, EAAT2 (GLT-1 in rodents) and EAAT1 (GLAST), the functional role of EAAT3/EAAC1 is related to the subtle regulation of glutamatergic transmission. Moreover, because it can also transport cysteine, EAAT3/EAAC1 is believed to be important for the synthesis of intracellular glutathione and subsequent protection from oxidative stress. In contrast to other EAATs, EAAT3/EAAC1 is mostly intracellular, and several mechanisms have been described for the rapid regulation of the membrane trafficking of the transporter. Moreover, the carrier interacts with several proteins, and this interaction modulates transport activity. Much less is known about the slow regulatory mechanisms acting on the expression of the transporter, although several recent reports have identified changes in EAAT3/EAAC1 protein level and activity related to modulation of its expression at the gene level. Moreover, EAAT3/EAAC1 expression is altered in pathological conditions, such as hypoxia/ischemia, multiple sclerosis, schizophrenia, and epilepsy. This review summarizes these results and provides an overall picture of changes in EAAT3/EAAC1 expression in health and disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Amara SG, Fontana AC (2002) Excitatory amino acid transporters: keeping up with glutamate. Neurochem Int 41(5):313–318. doi:10.1016/S0197-0186(02)00018-9

    CAS  PubMed  Google Scholar 

  2. Kanai Y, Hediger MA (2004) The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflugers Arch 447(5):469–479. doi:10.1007/s00424-003-1146-4

    CAS  PubMed  Google Scholar 

  3. Kanai Y, Hediger MA (2003) The glutamate and neutral amino acid transporter family: physiological and pharmacological implications. Eur J Pharmacol 479(1–3):237–247. doi:10.1016/j.ejphar.2003.08.073

    CAS  PubMed  Google Scholar 

  4. Kanai Y, Hediger MA (1992) Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360(6403):467–471. doi:10.1038/360467a0

    CAS  PubMed  Google Scholar 

  5. Gazzola GC, Dall’Asta V, Bussolati O, Makowske M, Christensen HN (1981) A stereoselective anomaly in dicarboxylic amino acid transport. J Biol Chem 256(12):6054–6059

    CAS  PubMed  Google Scholar 

  6. Billups B, Rossi D, Oshima T, Warr O, Takahashi M, Sarantis M, Szatkowski M, Attwell D (1998) Physiological and pathological operation of glutamate transporters. Prog Brain Res 116:45–57

    CAS  PubMed  Google Scholar 

  7. Zerangue N, Kavanaugh MP (1996) Flux coupling in a neuronal glutamate transporter. Nature 383(6601):634–637. doi:10.1038/383634a0

    CAS  PubMed  Google Scholar 

  8. Nothmann D, Leinenweber A, Torres-Salazar D, Kovermann P, Hotzy J, Gameiro A, Grewer C, Fahlke C (2010) Hetero-oligomerization of neuronal glutamate transporters. J Biol Chem 286(5):3935–3943. doi:10.1074/jbc.M110.187492

    PubMed Central  PubMed  Google Scholar 

  9. Leary GP, Holley DC, Stone EF, Lyda BR, Kalachev LV, Kavanaugh MP (2011) The central cavity in trimeric glutamate transporters restricts ligand diffusion. Proc Natl Acad Sci USA 108(36):14980–14985. doi:10.1073/pnas.1108785108

    CAS  PubMed Central  PubMed  Google Scholar 

  10. Seal RP, Amara SG (1999) Excitatory amino acid transporters: a family in flux. Annu Rev Pharmacol Toxicol 39:431–456. doi:10.1146/annurev.pharmtox.39.1.431

    CAS  PubMed  Google Scholar 

  11. Perego C, Di Cairano ES, Ballabio M, Magnaghi V (2011) Neurosteroid allopregnanolone regulates EAAC1-mediated glutamate uptake and triggers actin changes in Schwann cells. J Cell Physiol 227(4):1740–1751. doi:10.1002/jcp.22898

    Google Scholar 

  12. Bailey CG, Ryan RM, Thoeng AD, Ng C, King K, Vanslambrouck JM, Auray-Blais C, Vandenberg RJ, Broer S, Rasko JE (2011) Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria. J Clin Invest 121(1):446–453. doi:10.1172/JCI44474

    CAS  PubMed Central  PubMed  Google Scholar 

  13. Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP, Amara SG (1995) An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375(6532):599–603. doi:10.1038/375599a0

    CAS  PubMed  Google Scholar 

  14. Arriza JL, Eliasof S, Kavanaugh MP, Amara SG (1997) Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci USA 94(8):4155–4160

    CAS  PubMed Central  PubMed  Google Scholar 

  15. Rothstein JD, Martin L, Levey AI, Dykes-Hoberg M, Jin L, Wu D, Nash N, Kuncl RW (1994) Localization of neuronal and glial glutamate transporters. Neuron 13(3):713–725. doi:10.1016/0896-6273(94)90038-817

    CAS  PubMed  Google Scholar 

  16. Coco S, Verderio C, Trotti D, Rothstein JD, Volterra A, Matteoli M (1997) Non-synaptic localization of the glutamate transporter EAAC1 in cultured hippocampal neurons. Eur J Neurosci 9(9):1902–1910

    CAS  PubMed  Google Scholar 

  17. Shashidharan P, Huntley GW, Murray JM, Buku A, Moran T, Walsh MJ, Morrison JH, Plaitakis A (1997) Immunohistochemical localization of the neuron-specific glutamate transporter EAAC1 (EAAT3) in rat brain and spinal cord revealed by a novel monoclonal antibody. Brain Res 773(1–2):139–148. doi:10.1016/S0006-8993(97)00921-9

    CAS  PubMed  Google Scholar 

  18. Holmseth S, Dehnes Y, Huang YH, Follin-Arbelet VV, Grutle NJ, Mylonakou MN, Plachez C, Zhou Y, Furness DN, Bergles DE, Lehre KP, Danbolt NC (2012) The density of EAAC1 (EAAT3) glutamate transporters expressed by neurons in the mammalian CNS. J Neurosci 32(17):6000–6013. doi:10.1523/JNEUROSCI.5347-11.2012

    CAS  PubMed  Google Scholar 

  19. Plaitakis A, Shashidharan P (2000) Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson’s disease. J Neurol 247(Suppl 2):II25–II35

    Google Scholar 

  20. Berman AE, Chan WY, Brennan AM, Reyes RC, Adler BL, Suh SW, Kauppinen TM, Edling Y, Swanson RA (2011) N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1−/− mouse. Ann Neurol 69(3):509–520. doi:10.1002/ana.22162

    CAS  PubMed  Google Scholar 

  21. Nafia I, Re DB, Masmejean F, Melon C, Kachidian P, Kerkerian-Le Goff L, Nieoullon A, Had-Aissouni L (2008) Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction. J Neurochem 105(2):484–496. doi:10.1111/j.1471-4159.2007.05146.x

    CAS  PubMed  Google Scholar 

  22. Kugler P, Schmitt A (1999) Glutamate transporter EAAC1 is expressed in neurons and glial cells in the rat nervous system. Glia 27(2):129–142. doi:10.1002/(SICI)1098-1136(199908)27:2<129:AID-GLIA3>3.0.CO;2-Y

    CAS  PubMed  Google Scholar 

  23. Domercq M, Sanchez-Gomez MV, Areso P, Matute C (1999) Expression of glutamate transporters in rat optic nerve oligodendrocytes. Eur J Neurosci 11(7):2226–2236. doi:10.1046/j.1460-9568.1999.00639.x

    CAS  PubMed  Google Scholar 

  24. Domercq M, Matute C (1999) Expression of glutamate transporters in the adult bovine corpus callosum. Brain Res Mol Brain Res 67(2):296–302. doi:10.1016/S0169-328X(99)00072-8

    CAS  PubMed  Google Scholar 

  25. van Landeghem FK, Stover JF, Bechmann I, Bruck W, Unterberg A, Buhrer C, von Deimling A (2001) Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat. Glia 35(3):167–179. doi:10.1002/glia.1082

    PubMed  Google Scholar 

  26. Palos TP, Ramachandran B, Boado R, Howard BD (1996) Rat C6 and human astrocytic tumor cells express a neuronal type of glutamate transporter. Brain Res Mol Brain Res 37(1–2):297–303

    CAS  PubMed  Google Scholar 

  27. Chaudhry FA, Lehre KP, van Lookeren Campagne M, Ottersen OP, Danbolt NC, Storm-Mathisen J (1995) Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15(3):711–720. doi:10.1016/0896-6273(95)90158-2

    CAS  PubMed  Google Scholar 

  28. Dehnes Y, Chaudhry FA, Ullensvang K, Lehre KP, Storm-Mathisen J, Danbolt NC (1998) The glutamate transporter EAAT4 in rat cerebellar Purkinje cells: a glutamate-gated chloride channel concentrated near the synapse in parts of the dendritic membrane facing astroglia. J Neurosci 18(10):3606–3619

    CAS  PubMed  Google Scholar 

  29. Conti F, DeBiasi S, Minelli A, Rothstein JD, Melone M (1998) EAAC1, a high-affinity glutamate transporter, is localized to astrocytes and GABAergic neurons besides pyramidal cells in the rat cerebral cortex. Cereb Cortex 8(2):108–116

    CAS  PubMed  Google Scholar 

  30. Yang W, Kilberg MS (2002) Biosynthesis, intracellular targeting, and degradation of the EAAC1 glutamate/aspartate transporter in C6 glioma cells. J Biol Chem 277(41):38350–38357. doi:10.1074/jbc.M202052200

    CAS  PubMed  Google Scholar 

  31. Gonzalez MI, Kazanietz MG, Robinson MB (2002) Regulation of the neuronal glutamate transporter excitatory amino acid carrier-1 (EAAC1) by different protein kinase C subtypes. Mol Pharmacol 62(4):901–910

    CAS  PubMed  Google Scholar 

  32. Fournier KM, Gonzalez MI, Robinson MB (2004) Rapid trafficking of the neuronal glutamate transporter, EAAC1: evidence for distinct trafficking pathways differentially regulated by protein kinase C and platelet-derived growth factor. J Biol Chem 279(33):34505–34513. doi:10.1074/jbc.M404032200

    CAS  PubMed  Google Scholar 

  33. Gonzalez MI, Bannerman PG, Robinson MB (2003) Phorbol myristate acetate-dependent interaction of protein kinase Calpha and the neuronal glutamate transporter EAAC1. J Neurosci 23(13):5589–5593

    CAS  PubMed  Google Scholar 

  34. Huang Y, Feng X, Sando JJ, Zuo Z (2006) Critical role of serine 465 in isoflurane-induced increase of cell-surface redistribution and activity of glutamate transporter type 3. J Biol Chem 281(50):38133–38138. doi:10.1074/jbc.M603885200

    CAS  PubMed  Google Scholar 

  35. Klaus F, Gehring EM, Zurn A, Laufer J, Lindner R, Strutz-Seebohm N, Tavare JM, Rothstein JD, Boehmer C, Palmada M, Gruner I, Lang UE, Seebohm G, Lang F (2009) Regulation of the Na(+)-coupled glutamate transporter EAAT3 by PIKfyve. Neurochem Int 54(5–6):372–377

    CAS  PubMed  Google Scholar 

  36. Fedorenko O, Tang C, Sopjani M, Foller M, Gehring EM, Strutz-Seebohm N, Ureche ON, Ivanova S, Semke A, Lang F, Seebohm G, Lang UE (2009) PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3. Psychopharmacology 206(3):429–435. doi:10.1007/s00213-009-1621-5

    CAS  PubMed  Google Scholar 

  37. Almilaji A, Pakladok T, Guo A, Munoz C, Foller M, Lang F (2012) Regulation of the glutamate transporter EAAT3 by mammalian target of rapamycin mTOR. Biochem Biophys Res Commun 421(2):159–163. doi:10.1016/j.bbrc.2012.03.109

    CAS  PubMed  Google Scholar 

  38. Sopjani M, Alesutan I, Dermaku-Sopjani M, Fraser S, Kemp BE, Foller M, Lang F (2010) Down-regulation of Na+-coupled glutamate transporter EAAT3 and EAAT4 by AMP-activated protein kinase. J Neurochem 113(6):1426–1435. doi:10.1111/j.1471-4159.2010.06678.x

    CAS  PubMed  Google Scholar 

  39. Lin CI, Orlov I, Ruggiero AM, Dykes-Hoberg M, Lee A, Jackson M, Rothstein JD (2001) Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. Nature 410(6824):84–88. doi:10.1038/35065084

    CAS  PubMed  Google Scholar 

  40. Liu Y, Vidensky S, Ruggiero AM, Maier S, Sitte HH, Rothstein JD (2008) Reticulon RTN2B regulates trafficking and function of neuronal glutamate transporter EAAC1. J Biol Chem 283(10):6561–6571. doi:10.1074/jbc.M708096200

    CAS  PubMed Central  PubMed  Google Scholar 

  41. Aoyama K, Watabe M, Nakaki T (2011) Modulation of neuronal glutathione synthesis by EAAC1 and its interacting protein GTRAP3-18. Amino Acids 42(1):163–169. doi:10.1007/s00726-011-0861-y

    PubMed  Google Scholar 

  42. Aoyama K, Wang F, Matsumura N, Kiyonari H, Shioi G, Tanaka K, Kinoshita C, Kikuchi-Utsumi K, Watabe M, Nakaki T (2012) Increased neuronal glutathione and neuroprotection in GTRAP3-18-deficient mice. Neurobiol Dis 45(3):973–982. doi:10.1016/j.nbd.2011.12.016

    CAS  PubMed  Google Scholar 

  43. Butchbach ME, Lai L, Lin CL (2002) Molecular cloning, gene structure, expression profile and functional characterization of the mouse glutamate transporter (EAAT3) interacting protein GTRAP3-18. Gene 292(1–2):81–90. doi:10.1016/S0378-1119(02)00669-8

    CAS  PubMed  Google Scholar 

  44. Akiduki S, Ikemoto MJ (2008) Modulation of the neural glutamate transporter EAAC1 by the addicsin-interacting protein ARL6IP1. J Biol Chem 283(46):31323–31332. doi:10.1074/jbc.M801570200

    CAS  PubMed  Google Scholar 

  45. Gonzalez MI, Susarla BT, Fournier KM, Sheldon AL, Robinson MB (2007) Constitutive endocytosis and recycling of the neuronal glutamate transporter, excitatory amino acid carrier 1. J Neurochem 103(5):1917–1931. doi:10.1111/j.1471-4159.2007.04881.x

    CAS  PubMed  Google Scholar 

  46. Fournier KM, Robinson MB (2006) A dominant-negative variant of SNAP-23 decreases the cell surface expression of the neuronal glutamate transporter EAAC1 by slowing constitutive delivery. Neurochem Int 48(6–7):596–603. doi:10.1016/j.neuint.2005.12.030

    CAS  PubMed  Google Scholar 

  47. Gonzalez MI, Krizman-Genda E, Robinson MB (2007) Caveolin-1 regulates the delivery and endocytosis of the glutamate transporter, excitatory amino acid carrier 1. J Biol Chem 282(41):29855–29865. doi:10.1074/jbc.M704738200

    CAS  PubMed  Google Scholar 

  48. Xia P, Pei G, Schwarz W (2006) Regulation of the glutamate transporter EAAC1 by expression and activation of delta-opioid receptor. Eur J Neurosci 24(1):87–93. doi:10.1111/j.1460-9568.2006.04897.x

    CAS  PubMed  Google Scholar 

  49. Bianchi MG, Gatti R, Torielli L, Padoani G, Gazzola GC, Bussolati O (2010) The glutamate transporter excitatory amino acid carrier 1 associates with the actin-binding protein alpha-adducin. Neuroscience 169(2):584–595. doi:10.1016/j.neuroscience.2010.05.029

    CAS  PubMed  Google Scholar 

  50. Seidel B, Zuschratter W, Wex H, Garner CC, Gundelfinger ED (1995) Spatial and sub-cellular localization of the membrane cytoskeleton-associated protein alpha-adducin in the rat brain. Brain Res 700(1–2):13–24. doi:10.1016/0006-8993(95)00962-P

    CAS  PubMed  Google Scholar 

  51. Nieoullon A, Canolle B, Masmejean F, Guillet B, Pisano P, Lortet S (2006) The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse? J Neurochem 98(4):1007–1018. doi:10.1111/j.1471-4159.2006.03978.x

    CAS  PubMed  Google Scholar 

  52. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16(3):675–686. doi:10.1016/S0896-6273(00)80086-0

    CAS  PubMed  Google Scholar 

  53. Peghini P, Janzen J, Stoffel W (1997) Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration. EMBO J 16(13):3822–3832. doi:10.1093/emboj/16.13.3822

    CAS  PubMed Central  PubMed  Google Scholar 

  54. Aoyama K, Suh SW, Hamby AM, Liu J, Chan WY, Chen Y, Swanson RA (2006) Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat Neurosci 9(1):119–126. doi:10.1038/nn1609

    CAS  PubMed  Google Scholar 

  55. Lee S, Park SH, Zuo Z (2012) Effects of isoflurane on learning and memory functions of wild-type and glutamate transporter type 3 knockout mice. J Pharm Pharmacol 64(2):302–307. doi:10.1111/j.2042-7158.2011.01404.x

    CAS  PubMed  Google Scholar 

  56. Smith CP, Weremowicz S, Kanai Y, Stelzner M, Morton CC, Hediger MA (1994) Assignment of the gene coding for the human high-affinity glutamate transporter EAAC1 to 9p24: potential role in dicarboxylic aminoaciduria and neurodegenerative disorders. Genomics 20(2):335–336. doi:10.1006/geno1994.1183

    CAS  PubMed  Google Scholar 

  57. Bergles DE, Diamond JS, Jahr CE (1999) Clearance of glutamate inside the synapse and beyond. Curr Opin Neurobiol 9(3):293–298. doi:10.1016/S0959-4388(99)80043-9

    CAS  PubMed  Google Scholar 

  58. Zerangue N, Kavanaugh MP (1996) Interaction of L-cysteine with a human excitatory amino acid transporter. J Physiol 493(Pt 2):419–423

    CAS  PubMed Central  PubMed  Google Scholar 

  59. Chen Y, Swanson RA (2003) The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures. J Neurochem 84(6):1332–1339. doi:10.1046/j.1471-4159.2003.01630.x

    CAS  PubMed  Google Scholar 

  60. Shanker G, Allen JW, Mutkus LA, Aschner M (2001) The uptake of cysteine in cultured primary astrocytes and neurons. Brain Res 902(2):156–163. doi:10.1016/S0006-8993(01)02342-3

    CAS  PubMed  Google Scholar 

  61. Himi T, Ikeda M, Yasuhara T, Nishida M, Morita I (2003) Role of neuronal glutamate transporter in the cysteine uptake and intracellular glutathione levels in cultured cortical neurons. J Neural Transm 110(12):1337–1348. doi:10.1007/s00702-003-0049-z

    CAS  PubMed  Google Scholar 

  62. De Bundel D, Schallier A, Loyens E, Fernando R, Miyashita H, Van Liefferinge J, Vermoesen K, Bannai S, Sato H, Michotte Y, Smolders I, Massie A (2011) Loss of system x(c)- does not induce oxidative stress but decreases extracellular glutamate in hippocampus and influences spatial working memory and limbic seizure susceptibility. J Neurosci 31(15):5792–5803. doi:10.1523/JNEUROSCI.5465-10.2011

    PubMed  Google Scholar 

  63. Li X, Valencia A, Sapp E, Masso N, Alexander J, Reeves P, Kegel KB, Aronin N, Difiglia M (2010) Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington’s disease. J Neurosci 30(13):4552–4561. doi:10.1523/JNEUROSCI.5865-09.2010

    CAS  PubMed Central  PubMed  Google Scholar 

  64. Cao L, Li L, Zuo Z (2012) N-Acetylcysteine reverses existing cognitive impairment and increased oxidative stress in glutamate transporter type 3 deficient mice. Neuroscience. doi:10.1016/j.neuroscience.2012.06.044

    Google Scholar 

  65. Sepkuty JP, Cohen AS, Eccles C, Rafiq A, Behar K, Ganel R, Coulter DA, Rothstein JD (2002) A neuronal glutamate transporter contributes to neurotransmitter GABA synthesis and epilepsy. J Neurosci 22(15):6372–6379

    CAS  PubMed Central  PubMed  Google Scholar 

  66. Levenson J, Weeber E, Selcher JC, Kategaya LS, Sweatt JD, Eskin A (2002) Long-term potentiation and contextual fear conditioning increase neuronal glutamate uptake. Nat Neurosci 5(2):155–161. doi:10.1038/nn791

    CAS  PubMed  Google Scholar 

  67. Pita-Almenar JD, Collado MS, Colbert CM, Eskin A (2006) Different mechanisms exist for the plasticity of glutamate reuptake during early long-term potentiation (LTP) and late LTP. J Neurosci 26(41):10461–10471. doi:10.1523/JNEUROSCI.2579-06.2006

    CAS  PubMed  Google Scholar 

  68. Andin J, Hallbeck M, Mohammed AH, Marcusson J (2007) Influence of environmental enrichment on steady-state mRNA levels for EAAC1, AMPA1 and NMDA2A receptor subunits in rat hippocampus. Brain Res 1174:18–27. doi:10.1016/j.brainres.2007.06.101

    CAS  PubMed  Google Scholar 

  69. Scimemi A, Tian H, Diamond JS (2009) Neuronal transporters regulate glutamate clearance, NMDA receptor activation, and synaptic plasticity in the hippocampus. J Neurosci 29(46):14581–14595. doi:10.1523/JNEUROSCI.4845-09.2009

    CAS  PubMed Central  PubMed  Google Scholar 

  70. Do SH, Fang HY, Ham BM, Zuo Z (2002) The effects of lidocaine on the activity of glutamate transporter EAAT3: the role of protein kinase C and phosphatidylinositol 3-kinase. Anesth Analg 95(5):1263–1268

    CAS  PubMed  Google Scholar 

  71. Huang Y, Zuo Z (2003) Isoflurane enhances the expression and activity of glutamate transporter type 3 in C6 glioma cells. Anesthesiology 99(6):1346–1353. doi:10.1097/00000542-200312000-00016

    CAS  PubMed  Google Scholar 

  72. Lee G, Huang Y, Washington JM, Briggs NW, Zuo Z (2005) Carbamazepine enhances the activity of glutamate transporter type 3 via phosphatidylinositol 3-kinase. Epilepsy Res 66(1–3):145–153. doi:10.1016/j.eplepsyres.2005.08.003

    CAS  PubMed  Google Scholar 

  73. Furuta A, Rothstein JD, Martin LJ (1997) Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J Neurosci 17(21):8363–8375

    CAS  PubMed  Google Scholar 

  74. Furuta A, Takashima S, Yokoo H, Rothstein JD, Wada K, Iwaki T (2005) Expression of glutamate transporter subtypes during normal human corticogenesis and type II lissencephaly. Brain Res Dev Brain Res 155(2):155–164. doi:10.1016/j.devbrainres.2005.01.005

    CAS  PubMed  Google Scholar 

  75. Guillet B, Lortet S, Masmejean F, Samuel D, Nieoullon A, Pisano P (2002) Developmental expression and activity of high affinity glutamate transporters in rat cortical primary cultures. Neurochem Int 40(7):661–671. doi:10.1016/S0197-0186(01)00110-3

    CAS  PubMed  Google Scholar 

  76. Lortet S, Canolle B, Masmejean F, Nieoullon A (2008) Plasma membrane expression of the neuronal glutamate transporter EAAC1 is regulated by glial factors: evidence for different regulatory pathways associated with neuronal maturation. Neurochem Int 52(7):1373–1382. doi:10.1016/j.neuint.2008.02.007

    CAS  PubMed  Google Scholar 

  77. Maragakis NJ, Dietrich J, Wong V, Xue H, Mayer-Proschel M, Rao MS, Rothstein JD (2004) Glutamate transporter expression and function in human glial progenitors. Glia 45(2):133–143. doi:10.1002/glia.10310

    PubMed  Google Scholar 

  78. Abney ER, Williams BP, Raff MC (1983) Tracing the development of oligodendrocytes from precursor cells using monoclonal antibodies, fluorescence-activated cell sorting, and cell culture. Dev Biol 100(1):166–171. doi:10.1016/0012-1606(83)90207-5

    CAS  PubMed  Google Scholar 

  79. Bianchi MG, Franchi-Gazzola R, Reia L, Allegri M, Uggeri J, Chiu M, Sala R, Bussolati O (2012) Valproic acid induces the glutamate transporter excitatory amino acid transporter-3 in human oligodendroglioma cells. Neuroscience 227:260–270. doi:10.1016/j.neuroscience.2012.09.055

    CAS  PubMed  Google Scholar 

  80. Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH (2004) Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci USA 101(47):16659–16664. doi:10.1073/pnas.0407643101

    CAS  PubMed Central  PubMed  Google Scholar 

  81. Shen S, Li J, Casaccia-Bonnefil P (2005) Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J Cell Biol 169(4):577–589. doi:10.1083/jcb.200412101

    CAS  PubMed Central  PubMed  Google Scholar 

  82. Bianchi MG, Gazzola GC, Tognazzi L, Bussolati O (2008) C6 glioma cells differentiated by retinoic acid overexpress the glutamate transporter excitatory amino acid carrier 1 (EAAC1). Neuroscience 151(4):1042–1052. doi:10.1016/j.neuroscience.2007.11.055

    CAS  PubMed  Google Scholar 

  83. Bianchi MG, Gazzola GC, Cagnin S, Kagechika H, Bussolati O (2009) The ATRA-dependent overexpression of the glutamate transporter EAAC1 requires RARbeta induction. Biochim Biophys Acta 1788(9):1861–1868. doi:10.1016/j.bbamem.2009.05.005

    CAS  PubMed  Google Scholar 

  84. Zhu W, Kanoh M, Ye P, Laszkiewicz I, Royland JE, Wiggins RC, Konat G (1992) Retinoic acid-regulated expression of proteolipid protein and myelin-associated glycoprotein genes in C6 glioma cells. J Neurosci Res 31(4):745–750. doi:10.1002/jnr.490310418

    CAS  PubMed  Google Scholar 

  85. Ferrer-Martinez A, Felipe A, Nicholson B, Casado J, Pastor-Anglada M, McGivan J (1995) Induction of the high-affinity Na(+)-dependent glutamate transport system XAG- by hypertonic stress in the renal epithelial cell line NBL-1. Biochem J 310(Pt 2):689–692

    CAS  PubMed Central  PubMed  Google Scholar 

  86. Franchi-Gazzola R, Visigalli R, Dall’Asta V, Sala R, Woo SK, Kwon HM, Gazzola GC, Bussolati O (2001) Amino acid depletion activates TonEBP and sodium-coupled inositol transport. Am J Physiol Cell Physiol 280(6):C1465–C1474

    CAS  PubMed  Google Scholar 

  87. Miyakawa H, Woo SK, Dahl SC, Handler JS, Kwon HM (1999) Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc Natl Acad Sci USA 96(5):2538–2542

    CAS  PubMed Central  PubMed  Google Scholar 

  88. McGivan JD, Nicholson B (1999) Regulation of high-affinity glutamate transport by amino acid deprivation and hyperosmotic stress. Am J Physiol 277(4 Pt 2):F498–F500

    CAS  PubMed  Google Scholar 

  89. Gazzola RF, Sala R, Bussolati O, Visigalli R, Dall’Asta V, Ganapathy V, Gazzola GC (2001) The adaptive regulation of amino acid transport system A is associated to changes in ATA2 expression. FEBS Lett 490(1–2):11–14. doi:10.1016/S0014-5793(01)02126-3

    CAS  PubMed  Google Scholar 

  90. Nicholson B, McGivan JD (1996) Induction of high affinity glutamate transport activity by amino acid deprivation in renal epithelial cells does not involve an increase in the amount of transporter protein. J Biol Chem 271(21):12159–12164

    CAS  PubMed  Google Scholar 

  91. Ma K, Zheng S, Zuo Z (2006) The transcription factor regulatory factor X1 increases the expression of neuronal glutamate transporter type 3. J Biol Chem 281(30):21250–21255. doi:10.1074/jbc.M600521200

    CAS  PubMed  Google Scholar 

  92. Feng C, Xu W, Zuo Z (2009) Knockout of the regulatory factor X1 gene leads to early embryonic lethality. Biochem Biophys Res Commun 386(4):715–717. doi:10.1016/j.bbrc.2009.06.111

    CAS  PubMed Central  PubMed  Google Scholar 

  93. Feng C, Zuo Z (2012) Regulatory factor X1-induced down-regulation of transforming growth factor beta2 transcription in human neuroblastoma cells. J Biol Chem 287(27):22730–22739. doi:10.1074/jbc.M111.338590

    CAS  PubMed Central  PubMed  Google Scholar 

  94. Vargas MR, Johnson JA (2009) The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev Mol Med 11:e17. doi:10.1017/S1462399409001094

    PubMed  Google Scholar 

  95. Escartin C, Won SJ, Malgorn C, Auregan G, Berman AE, Chen PC, Deglon N, Johnson JA, Suh SW, Swanson RA (2011) Nuclear factor erythroid 2-related factor 2 facilitates neuronal glutathione synthesis by upregulating neuronal excitatory amino acid transporter 3 expression. J Neurosci 31(20):7392–7401. doi:10.1523/JNEUROSCI.6577-10.2011

    CAS  PubMed Central  PubMed  Google Scholar 

  96. Aoyama K, Matsumura N, Watabe M, Wang F, Kikuchi-Utsumi K, Nakaki T (2011) Caffeine and uric acid mediate glutathione synthesis for neuroprotection. Neuroscience 181:206–215. doi:10.1016/j.neuroscience.2011.02.047

    CAS  PubMed  Google Scholar 

  97. Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X, Buko A, Chollate S, Ellrichmann G, Bruck W, Dawson K, Goelz S, Wiese S, Scannevin RH, Lukashev M, Gold R (2011) Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134(Pt 3):678–692. doi:10.1093/brain/awq386

    PubMed  Google Scholar 

  98. Scannevin RH, Chollate S, Jung MY, Shackett M, Patel H, Bista P, Zeng W, Ryan S, Yamamoto M, Lukashev M, Rhodes KJ (2012) Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway. J Pharmacol Exp Ther 341(1):274–284. doi:10.1124/jpet.111.190132

    CAS  PubMed  Google Scholar 

  99. Molteni R, Ying Z, Gomez-Pinilla F (2002) Differential effects of acute and chronic exercise on plasticity-related genes in the rat hippocampus revealed by microarray. Eur J Neurosci 16(6):1107–1116. doi:10.1046/j.1460-9568.2002.02158.x

    PubMed  Google Scholar 

  100. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433(7021):73–77. doi:10.1038/nature03180

    CAS  PubMed  Google Scholar 

  101. Ganel R, Ho T, Maragakis NJ, Jackson M, Steiner JP, Rothstein JD (2006) Selective up-regulation of the glial Na+ -dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection. Neurobiol Dis 21(3):556–567. doi:10.1016/j.nbd.2005.08.014

    CAS  PubMed  Google Scholar 

  102. Lyon L, Kew JN, Corti C, Harrison PJ, Burnet PW (2008) Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice. Synapse 62(11):842–850. doi:10.1002/syn.20553

    CAS  PubMed Central  PubMed  Google Scholar 

  103. Lin JA, Tsai RY, Lin YT, Lee MS, Cherng CH, Wong CS, Tzeng JI (2008) Amitriptyline pretreatment preserves the antinociceptive effect of morphine in pertussis toxin-treated rats by lowering CSF excitatory amino acid concentrations and reversing the downregulation of glutamate transporters. Brain Res 1232:61–69. doi:10.1016/j.brainres.2008.07.016

    CAS  PubMed  Google Scholar 

  104. Veenstra-VanderWeele J, Kim SJ, Gonen D, Hanna GL, Leventhal BL, Cook EH Jr (2001) Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early-onset obsessive-compulsive disorder. Mol Psychiatry 6(2):160–167. doi:10.1038/sj.mp.4000806

    CAS  PubMed  Google Scholar 

  105. Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH Jr, Hanna GL (2006) Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry 63(7):778–785. doi:10.1001/archpsyc.63.7.778

    CAS  PubMed  Google Scholar 

  106. Stewart SE, Fagerness JA, Platko J, Smoller JW, Scharf JM, Illmann C, Jenike E, Chabane N, Leboyer M, Delorme R, Jenike MA, Pauls DL (2007) Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 144B(8):1027–1033. doi:10.1002/ajmg.b.30533

    CAS  PubMed  Google Scholar 

  107. Veenstra-VanderWeele J, Xu T, Ruggiero AM, Anderson LR, Jones ST, Himle JA, Kennedy JL, Richter MA, Hanna GL, Arnold PD (2012) Functional studies and rare variant screening of SLC1A1/EAAC1 in males with obsessive-compulsive disorder. Psychiatr Genet 22(5):256–260. doi:10.1097/YPG.0b013e328353fb63

    CAS  PubMed  Google Scholar 

  108. Schallier A, Smolders I, Van Dam D, Loyens E, De Deyn PP, Michotte A, Michotte Y, Massie A (2011) Region- and age-specific changes in glutamate transport in the AbetaPP23 mouse model for Alzheimer’s disease. J Alzheimers Dis 24(2):287–300. doi:10.3233/JAD-2011-101005

    CAS  PubMed  Google Scholar 

  109. Cassano T, Serviddio G, Gaetani S, Romano A, Dipasquale P, Cianci S, Bellanti F, Laconca L, Romano AD, Padalino I, LaFerla FM, Nicoletti F, Cuomo V, Vendemiale G (2012) Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease. Neurobiol Aging 33(6):1121.e1–1121.e12. doi:10.1016/j.neurobiolaging.2011.09.021

    Google Scholar 

  110. Duerson K, Woltjer RL, Mookherjee P, Leverenz JB, Montine TJ, Bird TD, Pow DV, Rauen T, Cook DG (2009) Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer’s disease patients. Brain Pathol 19(2):267–278. doi:10.1111/j.1750-3639.2008.00186.x

    CAS  PubMed Central  PubMed  Google Scholar 

  111. Trotti D, Danbolt NC, Volterra A (1998) Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci 19(8):328–334. doi:10.1016/S0165-6147(98)01230-9

    CAS  PubMed  Google Scholar 

  112. Martin LJ, Brambrink AM, Lehmann C, Portera-Cailliau C, Koehler R, Rothstein J, Traystman RJ (1997) Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum. Ann Neurol 42(3):335–348. doi:10.1002/ana.410420310

    CAS  PubMed  Google Scholar 

  113. Fujita H, Sato K, Wen TC, Peng Y, Sakanaka M (1999) Differential expressions of glycine transporter 1 and three glutamate transporter mRNA in the hippocampus of gerbils with transient forebrain ischemia. J Cereb Blood Flow Metab 19(6):604–615. doi:10.1097/00004647-199906000-00003

    CAS  PubMed  Google Scholar 

  114. Raghavendra Rao VL, Rao AM, Dogan A, Bowen KK, Hatcher J, Rothstein JD, Dempsey RJ (2000) Glial glutamate transporter GLT-1 down-regulation precedes delayed neuronal death in gerbil hippocampus following transient global cerebral ischemia. Neurochem Int 36(6):531–537. doi:10.1016/S0197-0186(99)00153-9

    CAS  PubMed  Google Scholar 

  115. Han F, Shioda N, Moriguchi S, Qin ZH, Fukunaga K (2008) Downregulation of glutamate transporters is associated with elevation in extracellular glutamate concentration following rat microsphere embolism. Neurosci Lett 430(3):275–280. doi:10.1016/j.neulet.2007.11.021

    CAS  PubMed  Google Scholar 

  116. Rao VL, Dogan A, Todd KG, Bowen KK, Kim BT, Rothstein JD, Dempsey RJ (2001) Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain. J Neurosci 21(6):1876–1883

    CAS  PubMed  Google Scholar 

  117. Douen AG, Akiyama K, Hogan MJ, Wang F, Dong L, Chow AK, Hakim A (2000) Preconditioning with cortical spreading depression decreases intraischemic cerebral glutamate levels and down-regulates excitatory amino acid transporters EAAT1 and EAAT2 from rat cerebral cortex plasma membranes. J Neurochem 75(2):812–818

    CAS  PubMed  Google Scholar 

  118. Szatkowski M, Barbour B, Attwell D (1990) Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 348(6300):443–446. doi:10.1038/348443a0

    CAS  PubMed  Google Scholar 

  119. Montori S, Martinez-Villayandre B, Dos-Anjos S, Llorente IL, Burgin TC, Fernandez-Lopez A (2010) Age-dependent modifications in the mRNA levels of the rat excitatory amino acid transporters (EAATs) at 48hour reperfusion following global ischemia. Brain Res 1358:11–19. doi:10.1016/j.brainres.2010.08.020

    CAS  PubMed  Google Scholar 

  120. Gottlieb M, Domercq M, Matute C (2000) Altered expression of the glutamate transporter EAAC1 in neurons and immature oligodendrocytes after transient forebrain ischemia. J Cereb Blood Flow Metab 20(4):678–687. doi:10.1097/00004647-200004000-00005

    CAS  PubMed  Google Scholar 

  121. Arranz AM, Gottlieb M, Perez-Cerda F, Matute C (2009) Increased expression of glutamate transporters in subcortical white matter after transient focal cerebral ischemia. Neurobiol Dis 37(1):156–165. doi:10.1016/j.nbd.2009.09.019

    PubMed  Google Scholar 

  122. Hwang I, Lee JC, Yoo KY, Cho JH, Jung JY, Kang TC, Oh YS, Kim WK, Won M (2007) Transient ischemia-induced changes of excitatory amino acid carrier 1 in the ventral horn of the lumbar spinal cord in rabbits. Neurol Res 29(3):310–316. doi:10.1179/016164107X159153

    PubMed  Google Scholar 

  123. Kobayashi S, Millhorn DE (2001) Hypoxia regulates glutamate metabolism and membrane transport in rat PC12 cells. J Neurochem 76(6):1935–1948

    CAS  PubMed  Google Scholar 

  124. Romera C, Hurtado O, Botella SH, Lizasoain I, Cardenas A, Fernandez-Tome P, Leza JC, Lorenzo P, Moro MA (2004) In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-alpha pathway. J Neurosci 24(6):1350–1357. doi:10.1523/JNEUROSCI.1596-03.2004

    CAS  PubMed  Google Scholar 

  125. Pradillo JM, Hurtado O, Romera C, Cardenas A, Fernandez-Tome P, Alonso-Escolano D, Lorenzo P, Moro MA, Lizasoain I (2006) TNFR1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning. Neuroscience 138(4):1171–1178. doi:10.1016/j.neuroscience.2005.12.010

    CAS  PubMed  Google Scholar 

  126. Bigdeli MR, Hajizadeh S, Froozandeh M, Heidarianpour A, Rasoulian B, Asgari AR, Pourkhalili K, Khoshbaten A (2008) Normobaric hyperoxia induces ischemic tolerance and upregulation of glutamate transporters in the rat brain and serum TNF-alpha level. Exp Neurol 212(2):298–306. doi:10.1016/j.expneurol.2008.03.029

    CAS  PubMed  Google Scholar 

  127. Bigdeli MR, Rahnema M, Khoshbaten A (2009) Preconditioning with sublethal ischemia or intermittent normobaric hyperoxia up-regulates glutamate transporters and tumor necrosis factor-alpha converting enzyme in the rat brain. J Stroke Cerebrovasc Dis 18(5):336–342. doi:10.1016/j.jstrokecerebrovasdis.2008.12.005

    PubMed  Google Scholar 

  128. Won SJ, Yoo BH, Brennan AM, Shin BS, Kauppinen TM, Berman AE, Swanson RA, Suh SW (2010) EAAC1 gene deletion alters zinc homeostasis and exacerbates neuronal injury after transient cerebral ischemia. J Neurosci 30(46):15409–15418. doi:10.1523/JNEUROSCI.2084-10.2010

    CAS  PubMed  Google Scholar 

  129. Li L, Zuo Z (2011) Glutamate transporter type 3 knockout reduces brain tolerance to focal brain ischemia in mice. J Cereb Blood Flow Metab 31(5):1283–1292. doi:10.1038/jcbfm.2010.222

    PubMed Central  PubMed  Google Scholar 

  130. Chen WF, Sung CS, Jean YH, Su TM, Wang HC, Ho JT, Huang SY, Lin CS, Wen ZH (2010) Suppressive effects of intrathecal granulocyte colony-stimulating factor on excessive release of excitatory amino acids in the spinal cerebrospinal fluid of rats with cord ischemia: role of glutamate transporters. Neuroscience 165(4):1217–1232. doi:10.1016/j.neuroscience.2009.11.033

    CAS  PubMed  Google Scholar 

  131. DeSilva TM, Kabakov AY, Goldhoff PE, Volpe JJ, Rosenberg PA (2009) Regulation of glutamate transport in developing rat oligodendrocytes. J Neurosci 29(24):7898–7908. doi:10.1523/JNEUROSCI.6129-08.2009

    CAS  PubMed Central  PubMed  Google Scholar 

  132. Ohgoh M, Hanada T, Smith T, Hashimoto T, Ueno M, Yamanishi Y, Watanabe M, Nishizawa Y (2002) Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis. J Neuroimmunol 125(1–2):170–178. doi:10.1016/S0165-5728(02)00029-2

    CAS  PubMed  Google Scholar 

  133. Pitt D, Werner P, Raine CS (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6(1):67–70. doi:10.1038/71555

    CAS  PubMed  Google Scholar 

  134. Vallejo-Illarramendi A, Domercq M, Perez-Cerda F, Ravid R, Matute C (2006) Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol Dis 21(1):154–164. doi:10.1016/j.nbd.2005.06.017

    CAS  PubMed  Google Scholar 

  135. Newcombe J, Uddin A, Dove R, Patel B, Turski L, Nishizawa Y, Smith T (2008) Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol 18(1):52–61. doi:10.1111/j.1750-3639.2007.00101.x

    PubMed  Google Scholar 

  136. Klemann C, Raveney BJ, Klemann AK, Ozawa T, von Horsten S, Shudo K, Oki S, Yamamura T (2009) Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis. Am J Pathol 174(6):2234–2245. doi:10.2353/ajpath.2009.081084

    CAS  PubMed Central  PubMed  Google Scholar 

  137. Huang JK, Jarjour AA, Nait Oumesmar B, Kerninon C, Williams A, Krezel W, Kagechika H, Bauer J, Zhao C, Baron-Van Evercooren A, Chambon P, Ffrench-Constant C, Franklin RJ (2011) Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci 14(1):45–53. doi:10.1038/nn.2702

    CAS  PubMed Central  PubMed  Google Scholar 

  138. Crino PB, Jin H, Shumate MD, Robinson MB, Coulter DA, Brooks-Kayal AR (2002) Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia 43(3):211–218

    CAS  PubMed Central  PubMed  Google Scholar 

  139. Ross JR, Porter BE, Buckley PT, Eberwine JH, Robinson MB (2011) mRNA for the EAAC1 subtype of glutamate transporter is present in neuronal dendrites in vitro and dramatically increases in vivo after a seizure. Neurochem Int 58(3):366–375. doi:10.1016/j.neuint.2010.12.012

    CAS  PubMed Central  PubMed  Google Scholar 

  140. Zhang G, Raol YS, Hsu FC, Brooks-Kayal AR (2004) Long-term alterations in glutamate receptor and transporter expression following early-life seizures are associated with increased seizure susceptibility. J Neurochem 88(1):91–101. doi:10.1046/j.1471-4159.2003.02124.x

    CAS  PubMed  Google Scholar 

  141. Doi T, Ueda Y, Nagatomo K, Willmore LJ (2009) Role of glutamate and GABA transporters in development of pentylenetetrazol-kindling. Neurochem Res 34(7):1324–1331. doi:10.1007/s11064-009-9912-0

    Google Scholar 

  142. Voutsinos-Porche B, Koning E, Clement Y, Kaplan H, Ferrandon A, Motte J, Nehlig A (2006) EAAC1 glutamate transporter expression in the rat lithium-pilocarpine model of temporal lobe epilepsy. J Cereb Blood Flow Metab 26(11):1419–1430. doi:10.1038/sj.jcbfm.9600295

    CAS  PubMed  Google Scholar 

  143. Simantov R, Crispino M, Hoe W, Broutman G, Tocco G, Rothstein JD, Baudry M (1999) Changes in expression of neuronal and glial glutamate transporters in rat hippocampus following kainate-induced seizure activity. Brain Res Mol Brain Res 65(1):112–123. doi:10.1016/S0169-328X(98)00349-0

    CAS  PubMed  Google Scholar 

  144. Harrington EP, Moddel G, Najm IM, Baraban SC (2007) Altered glutamate receptor—transporter expression and spontaneous seizures in rats exposed to methylazoxymethanol in utero. Epilepsia 48(1):158–168. doi:10.1111/j.1528-1167.2006.00838.x

    CAS  PubMed  Google Scholar 

  145. Lu Z, Zhang W, Zhang N, Jiang J, Luo Q, Qiu Y (2008) The expression of glutamate transporters in chest compression-induced audiogenic epilepsy: a comparative study. Neurol Res 30(9):915–919. doi:10.1179/174313208X327964

    PubMed  Google Scholar 

  146. Proper EA, Hoogland G, Kappen SM, Jansen GH, Rensen MG, Schrama LH, van Veelen CW, van Rijen PC, van Nieuwenhuizen O, Gispen WH, de Graan PN (2002) Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 125(Pt 1):32–43

    CAS  PubMed  Google Scholar 

  147. Mathern GW, Mendoza D, Lozada A, Pretorius JK, Dehnes Y, Danbolt NC, Nelson N, Leite JP, Chimelli L, Born DE, Sakamoto AC, Assirati JA, Fried I, Peacock WJ, Ojemann GA, Adelson PD (1999) Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 52(3):453–472

    CAS  PubMed  Google Scholar 

  148. Rakhade SN, Loeb JA (2008) Focal reduction of neuronal glutamate transporters in human neocortical epilepsy. Epilepsia 49(2):226–236. doi:10.1111/j.1528-1167.2007.01310.x

    CAS  PubMed  Google Scholar 

  149. Dutuit M, Touret M, Szymocha R, Nehlig A, Belin MF, Didier-Bazes M (2002) Decreased expression of glutamate transporters in genetic absence epilepsy rats before seizure occurrence. J Neurochem 80(6):1029–1038

    CAS  PubMed  Google Scholar 

  150. Samadani U, Judkins AR, Akpalu A, Aronica E, Crino PB (2007) Differential cellular gene expression in ganglioglioma. Epilepsia 48(4):646–653. doi:10.1111/j.1528-1167.2007.00925.x

    CAS  PubMed  Google Scholar 

  151. White R, Hua Y, Scheithauer B, Lynch DR, Henske EP, Crino PB (2001) Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann Neurol 49(1):67–78

    CAS  PubMed  Google Scholar 

  152. Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH (2001) Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am J Psychiatry 158(9):1393–1399

    CAS  PubMed  Google Scholar 

  153. Shan D, Lucas EK, Drummond JB, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE (2013) Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia. Schizophr Res 144(1–3):1–8. doi:10.1016/j.schres.2012.12.019

    PubMed Central  PubMed  Google Scholar 

  154. Bauer D, Gupta D, Harotunian V, Meador-Woodruff JH, McCullumsmith RE (2008) Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia. Schizophr Res 104(1–3):108–120. doi:10.1016/j.schres.2008.06.012

    PubMed Central  PubMed  Google Scholar 

  155. Rao JS, Kellom M, Reese EA, Rapoport SI, Kim HW (2012) Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J Affect Disord 136(1–2):63–71. doi:10.1016/j.jad.2011.08.017

    CAS  PubMed Central  PubMed  Google Scholar 

  156. Lauriat TL, Dracheva S, Chin B, Schmeidler J, McInnes LA, Haroutunian V (2006) Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain. Neuroscience 137(3):843–851. doi:10.1016/j.neuroscience.2005.10.003

    CAS  PubMed  Google Scholar 

  157. McCullumsmith RE, Meador-Woodruff JH (2002) Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 26(3):368–375. doi:10.1016/S0893-133X(01)00370-0

    CAS  PubMed  Google Scholar 

  158. Nudmamud-Thanoi S, Piyabhan P, Harte MK, Cahir M, Reynolds GP (2007) Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia. J Neural Transm Suppl 72:281–285

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Research in the authors’ laboratory has been funded by FISM (Fondazione Italiana Sclerosi Multipla onlus), grant no. 2010/R/9 to OB.

Author information

Authors and Affiliations

  1. Unit of General Pathology, Department of Biomedical, Biotechnological and Translational Sciences (SBiBiT), University of Parma, Via Volturno 39, 43125, Parma, Italy

    Massimiliano G. Bianchi, Donatella Bardelli, Martina Chiu & Ovidio Bussolati

  2. Unit of Occupational Medicine, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy

    Massimiliano G. Bianchi

Authors
  1. Massimiliano G. Bianchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Donatella Bardelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martina Chiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ovidio Bussolati
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ovidio Bussolati.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bianchi, M.G., Bardelli, D., Chiu, M. et al. Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease. Cell. Mol. Life Sci. 71, 2001–2015 (2014). https://doi.org/10.1007/s00018-013-1484-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-013-1484-0

Keywords

Search

Navigation